AUSTRALIAN healthcare service
operator, Healthscope, is advising
its shareholders to accept a $2.7
billion dollar joint takeover offer
from private equity firms TPG and
Carlyle.
In what has become the largest
private equity takeover bid in four
years, shareholders are now staring
down the barrel of a 16% share
increase to $6.26 from Friday’s
closing price of $5.40.
Healthscope is Australia’s
second largest private hospital
provider operating 44 private
hospitals, as well as 45 medical
centres, pathology businesses and
a diagnostic imaging division
centred in major hospitals.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jul 10
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.